Relmada Therapeutics

$33.26
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.10 (+0.29%) As of 3:04 PM EDT today

Why Robinhood?

You can buy or sell RLMD and other stocks, options, and ETFs commission-free!

About RLMD

Relmada Therapeutics, Inc. Common Stock, also called Relmada Therapeutics, is a clinical-stage biotechnology company. Read More It engages in the development of d-methadone receptor antagonist, which is a chemical entity that addresses areas of high unmet medical need in the treatment of central nervous system diseases and other disorders. The company was founded on May 31, 2012 and is headquartered in New York, NY. The listed name for RLMD is Relmada Therapeutics, Inc. Common Stock.

Employees
4
Headquarters
New York, New York
Founded
2012
Market Cap
531.19M
Price-Earnings Ratio
Dividend Yield
Average Volume
121.88K
High Today
$34.97
Low Today
$32.50
Open Price
$33.52
Volume
156.77K
52 Week High
$54.00
52 Week Low
$22.40

Collections

RLMD Earnings

-$0.73
-$0.49
-$0.24
$0.00
Q4 2019
Q1 2020
Q2 2020
Q3 2020
Estimated
per share
Actual
Expected Nov 12, After Hours

You May Also Like